Wuhan Lab Develops Universal Nanovaccine for COVID Variants
The Wuhan Institute of Virology in China has developed a groundbreaking nanovaccine that aims to offer universal protection against all major COVID-19 variants and future coronavirus mutations. This advancement comes…